Skip to main content

Table 3 Treatment and clinical outcomes

From: Prognosis of liver abscess with no identified organism

  CNLA (n = 156) CPLA (n = 246) Causative organism P value
E.coli (n = 74) K.pneumoniae (n = 133) P value* Other (n = 39)
Invasive procedure, n(%) 108 (69.2%) 195 (79.3%) 54 (73.0%) 108 (81.2%) 0.17 33 (84.6%) 0.02
Metastatic infection, n(%) 2 (1.3%) 12 (4.9%) 4 (5.4%) 7 (5.3%) 0.96 1 (2.6%) 0.05
In-hospital mortality, n(%) 6 (3.8%) 12 (4.9%) 5 (6.8%) 4 (3.0%) 0.20 3 (7.7%) 0.63
Length of hospital stay, days, median (IQR) 14.8 (7.75) 17.9 (8) 20 (15) 18 (9.5) 0.09 17 (16) 0.03
Recurrence, n (%) 12 (7.7%) 17 (6.9%) 6 (8.1%) 5 (3.8%) 0.18 6 (15.4%) 0.77
  1. *P value was calculated on two groups of E.coli liver abscess and K.pneumoniae liver abscess